Andersson et al. found IDH1 and IDH2 mutations in 1 out of 288 pediatric ALL patients [19], and this supports our finding of the low incidence of IDH1 and IDH2 in ALL patients. This evidence concerns the gene IDH2 and acute lymphoblastic leukemia.